Venetoclax combined with azacitidine as an effective and safe salvage regimen for relapsed or refractory T-cell acute lymphoblastic leukemia: a case series

Leuk Lymphoma. 2021 Dec;62(13):3300-3303. doi: 10.1080/10428194.2021.1957876. Epub 2021 Jul 29.

Chao-Ling Wan^{1

2}, Jing-Ying Zou³, Man Qiao^{1

2}, Jia Yin^{1

2}, Xiang-Dong Shen^{1

2}, Qiao-Cheng Qiu^{1

2}, Song-Bai Liu⁴, Sheng-Li Xue^{1

2}

¹ National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
² Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
³ Faculty of Nursing, Suzhou Vocational Health College, Suzhou, China.
⁴ Suzhou Key Laboratory of Medical Biotechnology, Suzhou Vocational Health College, Suzhou, China.

No abstract available

Publication types